Welcome to Dispensed Daily, your daily dose of
Hello,
I'm Kimberly Leonard, and I'm guest hosting today's edition of
First, what everyone's talking about: Presumptive Democratic nominee Joe
Who are the power players influencing the Biden-Harris healthcare policy positions? We've got you covered right here.
If you'd like to subscribe to Business Insider to read even more of our reporting, I encourage you to use this 20% discount code for an annual subscription. Don't forget we also offer a one-month trial for only $1.
Today in healthcare: Healthcare executives are making predictions about how a Biden win would boost their businesses, the Trump administration wants rural communities to pitch them ideas to transform healthcare, and — back to coronavirus news — a look at how convalescent plasma works.
Healthcare leaders are getting serious about what a Biden victory would mean for their businesses. 4 top execs share how a Democratic presidency would boost the industry.
- Healthcare CEOs are giving investors a peek into how Democratic policies would help their their businesses.
- Biden has promised to extend the role of government insurance, but publicly financed plans are often run by private insurers.
- One healthcare CEO said he didn't think Biden would follow through on his promise to increase the corporate tax rate.
The Trump administration is taking ideas from rural communities to transform healthcare. We got an early look at the project.
- Yesterday, I went to the White House to hear about a new project the
Trump administration is launching to help rural communities get healthcare to more people. - I got to interview Seema Verma, who oversees Medicare and Medicaid, and Brad Smith, who oversees the innovation center.
- The project will award $5 million to 15 rural communities who can come up with their own ideas. Some ideas include better virtual care, home visits, or monitoring patients remotely.
- "It's about reforming the system," Verma told me.
In coronavirus news: Blood transfusions from recovered coronavirus patients could become the next FDA-approved treatment — here's how convalescent plasma works
- The FDA is considering authorizing convalescent plasma as an emergency treatment for COVID-19.
- The therapy involves treating sick patients with the blood of those who have already recovered.
- But researchers still need to prove that the treatments are safe.
Read the full story from Aria Bendix here >>
More stories we're reading:
- US inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine (Reuters)
- Russia has approved a coronavirus vaccine without widespread testing. Medical experts warn it could be dangerous.(Business Insider)
- CVS Health Hub openings back on track after Covid-19 shutdown (Forbes)
- New Zealand goes back into lockdown after reporting first new locally transmitted coronavirus cases in 102 days (Insider)
Thanks for reading! If you'd like to send me story ideas you can reach me at kleonard@businessinsider.com or follow me on Twitter at @LeonardKL. You can email the whole team your ideas at healthcare@businessinsider.com.
Click here to get Dispensed delivered to your inbox every day — and take care!
- Kimberly